On July 22, the Centers for Disease Control and Prevention (CDC) held a meeting of the Board of Scientific Counselors...
opioid reform Articles
Congress includes appropriation language about the Pain Management Best Practices report!
Your advocacy has made an impact. Congress has directed the Department of Health and Human Services to disseminate the...
Read U.S. Pain’s comment to the CDC
Approximately 5,400 individuals and organizations responded to the Centers for Disease Control and Prevention (CDC)’s...
Continuing to represent the patient voice–virtually
While most in-person conferences and meetings have been canceled or postponed as a result of the pandemic, U.S. Pain...
Join us as we fight for #aplanforpain!
We're dedicating today, June 11, to flooding policymakers with our request that they allocate funding for key...
CDC announces comment period to inform update of opioid guideline
On April 17, the Centers for Disease and Control and Prevention (CDC) opened an official docket requesting comments...
Federal appropriations requests submitted
Congress has been hard at work on emergency supplemental appropriations bills in response to the COVID-19 pandemic and...
CO: Let’s improve access to PT, OT, acupuncture, and certain pain medications
Colorado is considering a bill, HB 20-1085, that would help increase affordable access to some types of pain care. How...
2020 state pain policy trends round-up
State legislative sessions across the country are now in full swing! Here are some major trends we’re seeing related...
NY: Two exciting bills would help chronic pain community
Over the years, we've heard many stories from pain warriors who wished their health care providers knew more about...
U.S. Pain spearheads joint letter to Congress from 30 patient and professional groups
U.S. Pain Foundation recently spearheaded a joint letter to the U.S. House Energy and Commerce (E&C) Committee and...
Read U.S. Pain’s letter to the FDA
U.S. Pain Foundation was among several hundred organizations and individuals to weigh in on a recent Food and Drug...